Urinalysis Interpretation
I need to see the actual urinalysis results to provide a specific interpretation, but I can guide you through the systematic approach to interpreting any urinalysis based on current evidence-based guidelines.
Framework for Urinalysis Interpretation
Urinalysis must be interpreted as three integrated components—physical examination, chemical dipstick, and microscopic examination—never in isolation. 1
Chemical Dipstick Results
Leukocyte Esterase
- Positive leukocyte esterase indicates pyuria but does NOT diagnose infection without accompanying urinary symptoms (dysuria, frequency, urgency, fever >38.3°C, or gross hematuria). 2
- Sensitivity: 83-94% when UTI is clinically suspected; Specificity: 78%. 1
- A negative leukocyte esterase combined with negative nitrite effectively rules out UTI with 90.5% negative predictive value. 2
- False positives occur with contaminated specimens, oxidizing agents, and certain medications. 2
Nitrite
- Positive nitrite is highly specific (98-100%) for gram-negative bacteria but has poor sensitivity (19-48%). 1
- Negative nitrite does NOT exclude UTI, especially in patients who void frequently (requires 4-6 hours bladder dwell time). 2
- Combined leukocyte esterase OR nitrite positivity achieves 88-93% sensitivity and 72-79% specificity. 1
Blood/Hematuria
- Dipstick-positive blood must be confirmed with microscopic examination to distinguish true hematuria (≥3 RBCs/HPF) from hemoglobinuria or myoglobinuria. 1
- Trace blood without RBCs on microscopy suggests hemoglobinuria, myoglobinuria, or false-positive result. 2
Protein
- Dipstick proteinuria requires correlation with microscopic findings and clinical context. 3
- Persistent proteinuria (not transient) warrants further nephrology work-up. 3
Microscopic Examination
White Blood Cells
- ≥10 WBCs/HPF defines pyuria and is required before proceeding to urine culture. 2
- Pyuria alone has low positive predictive value (43-56%) for infection—it indicates genitourinary inflammation from many causes, not just infection. 2
- 2-5 WBCs/HPF is below the diagnostic threshold and insufficient to diagnose UTI. 2
Red Blood Cells
- ≥3 RBCs/HPF defines microscopic hematuria. 1
- Dysmorphic RBCs suggest glomerular disease; uniform RBCs suggest lower urinary tract source. 4
Epithelial Cells
- High epithelial cell counts indicate contamination—repeat collection using proper midstream clean-catch or catheterization. 2
Bacteria
- Bacteria on microscopy correlate with ≥10⁵ CFU/mL but require culture confirmation. 1
- Mixed bacterial flora indicates contamination, not polymicrobial infection (true polymicrobial UTI is rare, <3-11% of cases). 2
Casts
- Renal tubular epithelial casts, granular casts, and dysmorphic RBCs are often missed by clinical laboratories but are critical for diagnosing acute kidney injury. 4
Clinical Decision Algorithm
If Urinalysis Shows Pyuria (≥10 WBCs/HPF or Positive Leukocyte Esterase):
Step 1: Assess for Specific Urinary Symptoms
- Required symptoms: dysuria, frequency, urgency, fever >38.3°C, gross hematuria, suprapubic pain, or costovertebral angle tenderness. 2
- If NO specific urinary symptoms → This is asymptomatic bacteriuria—do NOT treat (except in pregnancy or before urologic procedures with mucosal bleeding). 2
Step 2: If Symptoms Present → Obtain Urine Culture Before Starting Antibiotics
- Culture is mandatory in: recurrent UTI, pregnancy, suspected pyelonephritis, catheterized patients, or when resistance is suspected. 2
- In uncomplicated cystitis with typical symptoms, empiric treatment without culture is acceptable. 2
Step 3: Empiric Treatment (if indicated)
- First-line: Nitrofurantoin 100 mg PO BID × 5-7 days (resistance <5%). 2
- Alternative: Fosfomycin 3 g PO single dose. 2
- Trimethoprim-sulfamethoxazole only if local resistance <20% and no recent exposure. 2
If Urinalysis Shows Hematuria:
Step 1: Confirm True Hematuria
- Microscopy must show ≥3 RBCs/HPF. 1
Step 2: Risk Stratification
- High-risk patients (age >35-40 years, smoking, occupational chemical exposure, history of gross hematuria) require urologic evaluation even after single positive UA. 5
- Low-risk patients with hematuria that resolves after UTI treatment can be observed; if persistent >6 weeks, proceed to imaging and cystoscopy. 2
If Urinalysis is Negative (No Leukocyte Esterase, No Nitrite, No Pyuria):
UTI is effectively ruled out—search for alternative diagnoses. 2
- Do NOT treat empirically based on symptoms alone without laboratory confirmation. 2
- In elderly patients, non-specific symptoms (confusion, falls, weakness) without urinary symptoms do NOT justify UTI work-up. 2
Critical Pitfalls to Avoid
- Never treat pyuria without urinary symptoms—15-50% of elderly patients have asymptomatic bacteriuria with pyuria. 2
- Never treat based on urine odor or cloudiness alone—these are not diagnostic of infection. 2
- Never order urinalysis in asymptomatic patients—screening is not recommended by any major organization. 5
- Never assume mixed flora represents infection—it indicates contamination requiring repeat collection. 2
- In catheterized patients, never screen for or treat asymptomatic bacteriuria—it is universal and treatment causes harm. 2
- Never continue antibiotics for contaminated cultures or asymptomatic bacteriuria—stop immediately to prevent resistance. 2
Special Population Considerations
Pediatric Patients (2-24 months with fever)
- Require both urinalysis AND culture before antibiotics. 5, 1
- 10-50% of culture-proven UTIs have false-negative urinalysis. 2
- Preferred collection: catheterization or suprapubic aspiration (bag specimens have only 15% positive predictive value). 2
Elderly/Long-Term Care Residents
- Evaluate only with acute onset of specific urinary symptoms—not confusion, falls, or functional decline alone. 2
- Asymptomatic bacteriuria prevalence: 15-50%; treatment provides no benefit and increases harm. 2
Pregnant Women
- Screen for and treat asymptomatic bacteriuria (exception to general rule). 2
Please provide the specific urinalysis results (leukocyte esterase, nitrite, blood, protein, pH, specific gravity, microscopy findings) along with the patient's symptoms, age, sex, and relevant medical history for a tailored interpretation and management plan.